(Reuters) -Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue growth next year. The vaccine maker, which is expected to unveil ...
The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...
Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...
Nov 20 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it secured a five-year loan of $1.5 billion from Ares Management (ARES.N), opens new tab, as it targets up to 10% revenue growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback